Viewing data from:

CARTEOLOL HYDROCHLORIDE

ANDA

CARTEOLOL HYDROCHLORIDE | A075476 | SANDOZ INC

1 strength0 unique patents0 unique exclusivities

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-07-15 | 2 NDCs

Highest NADAC/Unit

$1.59

per ml

Lowest NADAC/Unit

$1.35

per ml

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
61314023805CARTEOLOL HCL 1% EYE DROPS	$1.59	ML	Generic	—	2026-06-17
61314023810CARTEOLOL HCL 1% EYE DROPS	$1.35	ML	Generic	—	2026-06-17

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

VA Federal Supply Schedule

Government-negotiated contract prices | 3 NDCs (3 FSS)

Lowest Price

$3.70

Highest Price

$13.77

FSS NDCs

Big4 NDCs

Description	Price	Type	Vendor	Contract End
61314-0238-05CARTEOLOL 1% SOLN,OPH	$3.70	FSS	Sandoz, Inc.	08/14/2028
61314-0238-10CARTEOLOL 1% SOLN,OPH	$7.19	FSS	Sandoz, Inc.	08/14/2028
61314-0238-15CARTEOLOL 1% SOLN,OPH	$13.77	FSS	Sandoz, Inc.	08/14/2028

Source: VA Federal Supply Schedule (va.gov). Prices are government-negotiated contract prices.

API Supply Chain1 active DMF2 inactive

1 active API supplier hold Drug Master Files for this ingredient. Limited supplier base — potential supply chain risk.

LUSOCHIMICA SPACARTEOLOL HYDROCHLORIDE

DMF 125091997

EDMOND PHARMAInactiveCARTEOLOL HYDROCHLORIDE

DMF 127141997

AMSA SPAInactiveCARTEOLOL HYDROCHLORIDE

DMF 149462000

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Approval Letters

2 letters from Drugs@FDA

Date	Submission	Document
May 28, 2004	ORIG -1	View Letter (PDF)
Jan 3, 2000	ORIG -1	View Letter (PDF)

Source: Drugs@FDA application documents.

Products (1)

#001 — 1%

0 patents0 exclusivities▴

SOLUTION/DROPS;OPHTHALMIC | Approved: Jan 3, 2000

No patent or exclusivity listings for this strength.